$IKT 4 SEC Filings

Filed On	Filing
21 Oct 2026	Form 4: Wasserman Scott M., Director Granted 310,000 Stock Option (Right to Buy)
31 Jul 2026	Form 4: Ra Capital MANAGEMENT, L.p., 10% owner and 3 others Disposed of 18,030,000 shares (Other Transaction) · Acquired 18,030,000 Pre-Funded Warrant (Right to Buy) (Other Transaction)
31 Jul 2026	Form 4: Berman Dennis N, Director Received 21,854 shares by exercise or conversion ($27.5K)
30 Jun 2026	Form 4: Berman Dennis N, Director Granted 155,000 Stock Option (Right to Buy)
30 Jun 2026	Form 4: Canner David, Director Granted 155,000 Stock Option (Right to Buy)
30 Jun 2026	Form 4: Kush Arvind, Director Granted 155,000 Stock Option (Right to Buy)
30 Jun 2026	Form 4: Bellini Roberto, Director Granted 155,000 Stock Option (Right to Buy)
30 Jun 2026	Form 4: Aurentz Vincent, Director Granted 155,000 Stock Option (Right to Buy)
30 Jun 2026	Form 4: Munshi Amit, Director Granted 155,000 Stock Option (Right to Buy)
24 Feb 2026	Form 4: Aurentz Vincent, Director Returned 255,299 shares to the issuer
24 Feb 2026	Form 4: Cabell Christopher, President & Head of R&D Returned 338,282 shares to the issuer
24 Feb 2026	Form 4: Munshi Amit, Director Returned 19,089 shares to the issuer
07 Jan 2026	Form 4: Iwicki Mark T, Director Granted 4,982,706 Stock Option (Right to Buy)
07 Jan 2026	Form 4: Cabell Christopher, President & Head of R&D Granted 900,117 Stock Option (Right to Buy)
07 Jan 2026	Form 4: McIntyre David, Chief Financial Officer Granted 986,319 Stock Option (Right to Buy)
24 Nov 2025	Form 4: Sands Capital Life Sciences Pulse Fund II, L.p., 10% owner and 2 others Bought 2,068,965 shares ($3M)
28 Aug 2025	Form 4: Munshi Amit, Director Received 57,265 shares as a grant or award
02 Jul 2025	Form 4: Aurentz Vincent, Director Granted 108,176 Stock Option (Right to Buy)
02 Jul 2025	Form 4: Canner David, Director Granted 108,176 Stock Option (Right to Buy)
02 Jul 2025	Form 4: Munshi Amit, Director Granted 108,176 Stock Option (Right to Buy)

Comments